Use the Back button in your browser to see the other results of your search or to select another record.
| Efficacy and safety of two different flow rates of nasal high-flow therapy in preterm neonates >= 28 weeks of gestation: a randomized controlled trial [with consumer summary] |
| Balasubramanian H, Sakharkar S, Majarikar S, Srinivasan L, Kabra NS, Garg B, Ahmed J |
| American Journal of Perinatology 2022 Nov;39(15):1693-1701 |
| clinical trial |
| 10/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: Yes; Blind therapists: Yes; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
Copyright release for this abstract has not been granted.
|